Hot Topics / Moroccan Pharma
In 2020, PharmaBoardroom has met with stakeholders from across the Moroccan healthcare and life sciences industries. These interviewees range from general managers overseeing several countries in the region from a…
Bayer is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen.
Morocco acts as the Maghreb hub for Bayer’s activities where it is responsible for three countries, Tunisia, Algeria, and Morocco. Bayer has been present in Morocco for more than 50 years, through its pharmaceutical, MaterialScience and CropScience practice. They have one production plant in the country and around 70 percent of what they sell on the Moroccan market is produced locally.
Contact Details
3 Boulevard Mohamed Zerktouni 20100,
Casablanca, Morocco
Phone: +212 22 43 83 91
http://www.bayer.com/
In 2020, PharmaBoardroom has met with stakeholders from across the Moroccan healthcare and life sciences industries. These interviewees range from general managers overseeing several countries in the region from a…
Taher Hassen, GM for Morocco and Tunisia at Merck, gives insights into navigating market access in the complex Moroccan pharma market, outlines, the challenge of introducing biosimilars, and the enduring…
Salim El Guermai, CEO & head pharmacist of Galenica, a leading generics company in Morocco, presents the original mission of the company to provide high-quality affordable medicines to Moroccan patients…
Ali Besri, Pfizer Morocco GM and North Africa Lead reveals the importance of Morocco’s stability and assets allowing the country to be recognized internationally for its manufacturing investments and capabilities…
Pierre Behnam, general manager of Pierre Fabre in Morocco, breaks down the strong and long-standing footprint of the group in the country in the medical and dermo-cosmetic fields. On the…
Myriem Tamimy gives an overview of the ongoing situation for Janssen and pharma multinationals more generally in Morocco, discusses the next steps in the authorities’ pharma strategy and the role…
Saad Kanbris, who has been heading Novartis operations in Morocco, Tunisia & Libya since January 2018, discusses the importance of ‘the context’ and temporality while analyzing the improvement and the…
Alain Barry, managing director of MSD in Morocco, shares how the organization is partnering with the Moroccan healthcare community to ensure that patients have access to innovative therapies and vaccines.…
Sanaa Sayagh of Roche Morocco shares her commitment to bringing the latest immunotherapies to Moroccan patients through partnerships with health authorities and the Lalla Salma Foundation on creative access programs.…
CEO Abdelhakim Tahri introduces women’s health player Gynebio Pharma, how the company is disrupting the Moroccan pharmaceutical industry through its range of contraceptive and fertility products, and his vision for…
Yassine Houbachi discusses his strategy for leading Moroccan generics player Polymedic, the market environment in Morocco, and what future challenges may be. In addition, Houbachi introduces RIM Pharma, an innovative…
Multinational pharmaceutical companies are increasingly seeing Morocco as a top manufacturing destination for the African continent. Firms from Europe, Asia-Pacific and the US are investing millions of dollars in bolstering…
See our Cookie Privacy Policy Here
